Skip to main content
Clinical Trials/KCT0002021
KCT0002021Recruiting未知

Efficacy and Safety of Porcine Placenta Hydrolysate on menopausal symptoms; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

CellaMedic Korea0 sites100 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
40(Year) to 60(Year) (—)
Sex
All

Inclusion Criteria

  • 1) kupperman index = 30mm
  • 2) Subject who agrees to participate in the study and signs the informed consent form

Exclusion Criteria

  • 1) BMI(Body Mass Index) > 30Kg/m2
  • 2) Hormone therapy within the past 3 months
  • 3) Subject with uncontrolled hypertension (over 160/100mmHg, when measuring after 10 minutes steady)
  • 4) Subject with uncontrolled diabetes mellitus (more than 180mg/dl of fasting glucose)
  • 5) History of drug abuse, or alcoholism
  • 6) Subject with AST(GOT) or ALT(GPT) or ?-GTP = 3 times the upper limit of normal
  • 7) Subject with serum creatinine = 2 times the upper limit of normal
  • 8) Subject who participated in any clinical trial within 1 month or plan to participate in the other clinical study
  • 9) Inappropriate subject decided by the investigator

Investigators

Sponsor
CellaMedic Korea

Similar Trials